Cancer Guidelines
Chair, Cancer Guidelines Advisory Group, Medical Oncologist, BC Cancer Agency; Clinical Professor, School of Population and Public Health, University of British Columbia
George Browman, Chair of the Partnership’s Cancer Guidelines Advisory Group, is a medical oncologist at the BC Cancer Agency’s Vancouver Island Centre in Victoria. He also chairs the University of British Columbia BCCA Research Ethics Board and is a clinical professor in the School of Population and Public Health at the University of British Columbia
Dr. Browman holds an adjunct professorship in the Department of Oncology, University of Calgary, which he headed from 2004 to 2006, and is a part-time professor in the Department of Clinical Epidemiology and Biostatistics at McMaster University; he chaired that department from 1989 to 1997.
Dr. Browman is a 1971 medical graduate of Montreal’s McGill University and completed his specialty training at the University of Toronto and McMaster University. He received his Master’s Degree in Design, Measurement and Evaluation from McMaster in 1985. Dr. Browman chaired the health services committee for the American Society of Clinical Oncology from 2000 to 2002 and remains a member of its methodology subcommittee. He is an associate editor for the Journal of the National Cancer Institute.
Dr. Browman served as director of the Tom Baker Cancer Centre and vice-president of the Alberta Cancer Board from 2004 to 2006, and as president of the Juravinski Cancer Centre at Hamilton Health Sciences from 1999 to 2004. He was the founding director of Cancer Care Ontario’s program in evidence-based care.
In 2000, Dr. Browman received the National Cancer Institute of Canada’s O. Harold Warwick Prize for career contributions to cancer control in Canada. Dr. Browman’s research interests include health services with an emphasis on evidence-based health care and practice guideline development and implementation, and clinical trials. He is co–principal investigator for a 2007–2012 Canadian Institutes of Health Research New Emerging Team grant in health services research in cancer, with a focus on resource allocation decision-making. He continues to be involved in medical teaching and in clinical practice, with a focus on systemic therapy in head and neck cancer. Dr. Browman has published over 140 peer-reviewed articles.
Dr. Browman chairs the Partnership’s Cancer Guidelines Advisory Group and was a member of the Advisory Council on Cancer Control.
